Fri, Aug 29, 2014, 7:16 AM EDT - U.S. Markets open in 2 hrs 14 mins

Recent

% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

pensiveman2000 9 posts  |  Last Activity: Aug 16, 2014 3:54 PM Member since: Aug 3, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • I would be very interested in hearing the top one or two things that posters learned from their QCOR ride. I'll start and offer up a few.

    1. Not sure I "learned" it anew, but certainly had it reemphasized that great fundamental financial results do NOT have a direct and immediate correlation to the underlying stock price/action.

    2. An investor must be very careful to take anonymous guidance, particularly from shorts who not only have the same incentive as a pumper, but also have a time element to their objective, hence they are more determined and willing to go beyond the boundaries of credibility (a nice way of saying "lie through their teeth").

    3. Sometimes the easiest money to be made can be on the downside of a stock that has had a sudden rise.

    I have others, but would rather hear from other posters. Thanks in advance for your contributions to what I believe will be a highly educational list.

    Sentiment: Strong Buy

  • Reply to

    You guys still don't get it

    by doctorgreenback Jul 11, 2014 6:05 PM
    pensiveman2000 pensiveman2000 Jul 11, 2014 6:31 PM Flag

    doctorgreenback said an "unqualified" opinion was coming. Why do you lecture him or her on what a qualified opinion means? I'd try to read the message you are critiquing before making useless commentary.

  • Reply to

    All I know is Monday be huge collapse

    by ezgi.ulusoy Jun 14, 2014 12:10 AM
    pensiveman2000 pensiveman2000 Jun 14, 2014 4:05 PM Flag

    What can they do next?

    a. use their cash to find a suitor for the company
    b. use their cash to find a suitor for the assets
    c. use their cash to find a partner, like Takeda, to market/distribute the product
    d. use their cash to conclusively determine the cause of the deaths.
    e. depending on findings of "d", use their cash to pursue alternatives based on that information, some of which maybe a, b, or c above or f below.
    f. use their cash to liquidate the company.

    But throwing out the term "BK so reflexively, with no thought and no mention of the myriad of other options exposes you as either a total rookie or a disingenuous dispenser of fear, uncertainty and doubt. In any case, you you have no credibility with me.

  • Reply to

    I guess Takeda

    by oshinator54 Jun 14, 2014 11:51 AM
    pensiveman2000 pensiveman2000 Jun 14, 2014 2:22 PM Flag

    Ever heard of "sunk costs"? It could easily be that Takeda sees life in Omonty's but not sufficient life to warrant its continued involvement for numerous reasons. They are smart enough to know their analysis should be based on future prospects and investment and not on sunk costs.

  • pensiveman2000 pensiveman2000 Jun 14, 2014 2:20 PM Flag

    Since when does a stock's price give incontrovertible information as to the underlying company's health or prospects? Too many examples to even bother giving them of companies the market has left for dead that were not dead. Plus, your relentless repeating "its dead" does not make it so.
    Repeat it 1,000 more times and it will be immaterial on the reality of AFFY.

    It may well be dead, but the information we have right now is not at all conclusive.

  • Reply to

    Pulling of the NDA

    by nhood310 Jun 14, 2014 12:49 AM
    pensiveman2000 pensiveman2000 Jun 14, 2014 2:12 PM Flag

    There are numerous implications and possibilities here. I find it telling and almost comical how quickly the transparent shorts want to declare this is dead. It may well die in time as T backing away could be an ominous sign. However, it could also be that T backing away is necessary for AFFY to move forward with other, less cautious partners. For all the hysteria the shorts make of the few dozen deaths, the more than 25,000 patients benefited by Omontys suggests to me there is a market here, even if limited only to subQ administration. Do I know this for certainty? No, but neither do the shorts know for certainty that there are no discussions with candidate partners.

    One of the tell-tale signs of the fearmongering shorts is there consistent drum beat of AFFY needing to file BK. BK is for providing protection from creditors to allow an orderly reorganization or liquidation. I don't see that there are meaningful creditors here to justifythat time or expense. If the board wants to wind this thing down, they can do so w/o the fearmongering act of filing BK.

    The fact that AFFY is still alive, has cash on the balance sheet, has shed a cautious, slow to do due diligence on the deaths and recently burned Japanese partner suggests to me that AFFY is now free to chose a path wholly free from Takeda. Will this be good or will this be bad? I dunno and I'm sure the stock price will drop Monday, but until I hear more news, I'm drawing no conclusions positive or negative.

    Please note the PR statement said nothing about the investigations yielding information with regard to the death's possibly being due to the administration of Omonty's. Would the Fresenius relationship that Takeda has be more important than their investment in Omonty's??? I dunno, but it could be that T didn't want to take on F for numerous non-Omonty's related issues. In other words, until I know the full story, I'm not selling a share or jumping to rash conclusions.

  • Reply to

    major dumpage going on right now...

    by bbondslf25 Jun 11, 2014 10:57 AM
    pensiveman2000 pensiveman2000 Jun 11, 2014 12:27 PM Flag

    Why would the file BK? BK is to protect from creditors, they have virtually no creditors. Invoking BK is fearmongering, pure and simple.

  • pensiveman2000 pensiveman2000 Jun 9, 2014 12:57 AM Flag

    First off, Cigna is not "dropping Acthar". If you compare closely the wording of this bulletin to the last bulletin, you'll see Cigna actually deleted language that made their reimbursement policy in the new bulletin more certain.

    Specifically, in the 6/14 bulletin, Cigna has removed the language "when there is failure of corticosteroid therapy" as a condition for prescribing Acthar Gel. Strikes me as saying that prescribers can make their own decision when to prescribe Acthar Gel. For example: if a patient has a known bad history with corticosteroids, or the doc feels for any reason that Acthar offers a better outcome (e.g., violent and uncontrolled MS spasms or debilitating PM/DM)--they can skip corticosteroids and go straight to Acthar Gel.

    So spin it however you like, I just suggest to sincere investors that relying on statements of hyperbole like yours, eastsider_nyc, is very dangerous.

    Sentiment: Strong Buy

  • Reply to

    Corporate Governance in question

    by fdetcher Mar 10, 2014 3:42 PM
    pensiveman2000 pensiveman2000 Jun 6, 2014 5:24 PM Flag

    rav, no, I've been out of the stock since it was in the 3's, almost two years now. I do believe this stock has another ride up someday, I just don't know when. QCOR has been my obsession for the last few years and it has treated me well. I just wish I were better at moving in and out of it with all the short's games.

QCOR
93.600.00(0.00%)Aug 14 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.